PharmiWeb.com - Global Pharma News & Resources
24-Jan-2020

Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results

DUBLIN, Jan. 24, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2019 financial results on February 26, 2020 and members of its senior management team will host a conference call and webcast at 8:00am EST before the U.S. financial markets open.

The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 4777677. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from February 26, 2020 at 11:00 a.m. ET until 11:00 a.m. ET on March 4, 2020 by dialing U.S./Canada (800) 585-8367 International (404) 537-3406, and entering the passcode 4777677.

A simultaneous webcast of the call can be accessed by visiting http://investor.endo.com/events-and-presentations. In addition, a replay of the webcast will be available on the Company website for one year following the event.

About Endo International plc

Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

 

 

View original content:http://www.prnewswire.com/news-releases/endo-to-announce-fourth-quarter-and-full-year-2019-financial-results-300993018.html

SOURCE Endo International plc

Editor Details

Last Updated: 24-Jan-2020